Gates Research Institute to develop Glaxo's promising TB vaccine (Bloomberg, 27 Jan '20)

Published on January 27, 2020

GlaxoSmithKline Plc licensed a promising vaccine against tuberculosis to the Bill & Melinda Gates Medical Research Institute in a move the drugmaker said will help bring prevention of the deadly disease to poor countries.

The Gates group will lead development of the vaccine candidate and sponsor future clinical tests, London-based Glaxo said in an emailed statement. Financial terms of the agreement weren’t provided.

Read full article HERE

Other news

Surviving TB: What can we learn and do better?

January 9, 2020
Read our first Blog post by @Deepti C on "Surviving TB: What can we learn and do better". A passionate perspective from a TB survivor, outlining important points for the TB community to take in. Please read and comments welcome!Check out our new Blog section.With this we are wrapping up the discussions around our first Webinar theme "Surviving TB" - You can find background and watch the webinar ba

Greater private sector participation in TB drive - The Philippines, Daily Tribune, 19 Feb 2020

February 19, 2020
BUSINESS Greater private sector participation in TB drive TDT Published 1 day ago on February 19, 2020 03:00 AMBy TDT Representatives from the Department of Health-National TB Control Program (DoH-NTP), Department of Labor and Employment (DoLE), and Bureau of International Health Cooperation (BIHC) discuss how the private sector can participate in the TB control program at the Forum on Increasing